Lung Kee Calls 2026 AGM, Seeks Share Issue Mandate and Board Re-elections

Lung Kee (Bermuda) Holdings Limited ( (HK:0255) ) just unveiled an announcement.

Lung Kee Group Holdings Limited has called its annual general meeting for 18 May 2026 in Hong Kong, where shareholders will review the audited financial statements for the year ended 31 December 2025 and vote on a proposed final dividend. The meeting will also address board structure and governance matters, including capping the number of directors at 15, re-electing three executive directors, authorizing the board to set directors’ and auditor’s remuneration, fill casual board vacancies, and approve a general mandate to issue up to 20% of the company’s existing share capital, potentially providing funding flexibility for future corporate or capital market actions.

These resolutions, if approved, will reinforce the company’s existing leadership while giving the board broader authority over capital management and board appointments. The share issue mandate in particular would increase financial and strategic agility, which may affect future equity dilution and governance dynamics for shareholders.

The most recent analyst rating on (HK:0255) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Lung Kee (Bermuda) Holdings Limited stock, see the HK:0255 Stock Forecast page.

More about Lung Kee (Bermuda) Holdings Limited

Lung Kee Group Holdings Limited is a Hong Kong-listed company incorporated in Bermuda. It operates in the industrial manufacturing sector, with a focus likely related to mold bases and related engineering products, serving customers in manufacturing and tooling-intensive industries in Asia and beyond.

Average Trading Volume: 86,593

Technical Sentiment Signal: Buy

Current Market Cap: HK$950.8M

For an in-depth examination of 0255 stock, go to TipRanks’ Overview page.